214 related articles for article (PubMed ID: 36714553)
41.
Hang L; Kumar S; Blum AM; Urban JF; Fantini MC; Weinstock JV
J Immunol; 2019 Apr; 202(8):2473-2481. PubMed ID: 30850474
[TBL] [Abstract][Full Text] [Related]
42. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
[TBL] [Abstract][Full Text] [Related]
43. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease.
Sturm A; Schulte C; Schatton R; Becker A; Cario E; Goebell H; Dignass AU
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):445-50. PubMed ID: 10783999
[TBL] [Abstract][Full Text] [Related]
44. Oral administration of transforming growth factor-β1 (TGF-β1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor κB (NF-κB) signaling and proinflammatory cytokine production.
Shiou SR; Yu Y; Guo Y; Westerhoff M; Lu L; Petrof EO; Sun J; Claud EC
J Biol Chem; 2013 Nov; 288(48):34757-66. PubMed ID: 24129565
[TBL] [Abstract][Full Text] [Related]
45. The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.
Liberek A; Kmieć Z; Kartanowicz D; Wierzbicki PM; Stanisławowski M; Kaszubowska L; Luczak G; Góra-Gębka M; Landowski P; Szlagatys-Sidorkiewicz A; Liberek T; Kamińska B; Jakóbkiewicz-Banecka J; Węgrzyn G
Int J Colorectal Dis; 2013 Feb; 28(2):165-72. PubMed ID: 22584294
[TBL] [Abstract][Full Text] [Related]
46. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease.
Babyatsky MW; Rossiter G; Podolsky DK
Gastroenterology; 1996 Apr; 110(4):975-84. PubMed ID: 8613031
[TBL] [Abstract][Full Text] [Related]
47. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.
Ihara S; Hirata Y; Koike K
J Gastroenterol; 2017 Jul; 52(7):777-787. PubMed ID: 28534191
[TBL] [Abstract][Full Text] [Related]
48. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein.
Boyer Arnold N; Korc M
J Biol Chem; 2005 Jun; 280(23):21858-66. PubMed ID: 15811853
[TBL] [Abstract][Full Text] [Related]
49. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
50. Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling.
Lee YS; Kim JH; Kim ST; Kwon JY; Hong S; Kim SJ; Park SH
Biochem Biophys Res Commun; 2010 Mar; 393(4):836-43. PubMed ID: 20171181
[TBL] [Abstract][Full Text] [Related]
51. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine.
Lawrance IC; Maxwell L; Doe W
Inflamm Bowel Dis; 2001 Feb; 7(1):16-26. PubMed ID: 11233656
[TBL] [Abstract][Full Text] [Related]
52. Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis.
Namachivayam K; Blanco CL; MohanKumar K; Jagadeeswaran R; Vasquez M; McGill-Vargas L; Garzon SA; Jain SK; Gill RK; Freitag NE; Weitkamp JH; Seidner SR; Maheshwari A
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(2):G167-80. PubMed ID: 23154975
[TBL] [Abstract][Full Text] [Related]
53. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
[TBL] [Abstract][Full Text] [Related]
54. Reprogramming the immune system in IBD.
MacDonald TT; Vossenkaemper A; Fantini M; Monteleone G
Dig Dis; 2012; 30(4):392-5. PubMed ID: 22796803
[TBL] [Abstract][Full Text] [Related]
55. The differential regulation of Smad7 in kidney tubule cells by connective tissue growth factor and transforming growth factor-beta1.
Qi W; Chen X; Twigg S; Zhang Y; Gilbert RE; Kelly DJ; Pollock CA
Nephrology (Carlton); 2007 Jun; 12(3):267-74. PubMed ID: 17498122
[TBL] [Abstract][Full Text] [Related]
56. Smad7 inhibits TGF-β1-induced MCP-1 upregulation through a MAPK/p38 pathway in rat peritoneal mesothelial cells.
Wang X; Li X; Ye L; Chen W; Yu X
Int Urol Nephrol; 2013 Jun; 45(3):899-907. PubMed ID: 23242502
[TBL] [Abstract][Full Text] [Related]
57. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
[TBL] [Abstract][Full Text] [Related]
58. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
[TBL] [Abstract][Full Text] [Related]
59. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
60. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease.
Hahm KB; Im YH; Parks TW; Park SH; Markowitz S; Jung HY; Green J; Kim SJ
Gut; 2001 Aug; 49(2):190-8. PubMed ID: 11454793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
